- Home
- RXO vs ZLAB Comparison
RXO vs ZLAB Comparison
Compare RXO & ZLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RXO
- ZLAB
- Stock Information
- Founded
- RXO 2022
- ZLAB 2013
- Country
- RXO United States
- ZLAB China
- Employees
- RXO N/A
- ZLAB N/A
- Industry
- RXO
- ZLAB Biotechnology: Pharmaceutical Preparations
- Sector
- RXO
- ZLAB Health Care
- Exchange
- RXO Nasdaq
- ZLAB Nasdaq
- Market Cap
- RXO 2.6B
- ZLAB 2.2B
- IPO Year
- RXO N/A
- ZLAB 2017
- Fundamental
- Price
- RXO $12.89
- ZLAB $19.88
- Analyst Decision
- RXO Hold
- ZLAB Buy
- Analyst Count
- RXO 15
- ZLAB 6
- Target Price
- RXO $16.33
- ZLAB $57.22
- AVG Volume (30 Days)
- RXO 2.5M
- ZLAB 931.8K
- Earning Date
- RXO 11-06-2025
- ZLAB 11-06-2025
- Dividend Yield
- RXO N/A
- ZLAB N/A
- EPS Growth
- RXO N/A
- ZLAB N/A
- EPS
- RXO N/A
- ZLAB N/A
- Revenue
- RXO $5,940,000,000.00
- ZLAB $441,629,000.00
- Revenue This Year
- RXO $30.18
- ZLAB $40.71
- Revenue Next Year
- RXO $6.30
- ZLAB $50.42
- P/E Ratio
- RXO N/A
- ZLAB N/A
- Revenue Growth
- RXO 53.85
- ZLAB 24.14
- 52 Week Low
- RXO $10.43
- ZLAB $19.51
- 52 Week High
- RXO $31.11
- ZLAB $44.34
- Technical
- Relative Strength Index (RSI)
- RXO 45.81
- ZLAB 18.64
- Support Level
- RXO $10.45
- ZLAB $19.51
- Resistance Level
- RXO $11.37
- ZLAB $20.29
- Average True Range (ATR)
- RXO 1.03
- ZLAB 0.76
- MACD
- RXO 0.06
- ZLAB 0.02
- Stochastic Oscillator
- RXO 44.05
- ZLAB 7.44
About RXO RXO Inc.
RXO Inc is a brokered transportation platform defined by cutting-edge technology and a nimble, asset-light business model, with the component being core truck brokerage business. Its operations also include three asset-light, brokered transportation services, all of which complement its truck brokerage business: managed transportation, last mile and freight forwarding. The company operates into one reportable segment. The operates within the transportation industry and in the same geography North America.
About ZLAB Zai Lab Limited
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.